Literature DB >> 30529662

A comparison of the in vitro permeation of niacinamide in mammalian skin and in the Parallel Artificial Membrane Permeation Assay (PAMPA) model.

Yanling Zhang1, Majella E Lane2, Jonathan Hadgraft2, Michael Heinrich2, Tao Chen3, Guoping Lian4, Balint Sinko5.   

Abstract

The in vitro skin penetration of pharmaceutical or cosmetic ingredients is usually assessed in human or animal tissue. However, there are ethical and practical difficulties associated with sourcing these materials; variability between donors may also be problematic when interpreting experimental data. Hence, there has been much interest in identifying a robust and high throughput model to study skin permeation that would generate more reproducible results. Here we investigate the permeability of a model active, niacinamide (NIA), in (i) conventional vertical Franz diffusion cells with excised human skin or porcine skin and (ii) a recently developed Parallel Artificial Membrane Permeation Assay (PAMPA) model. Both finite and infinite dose conditions were evaluated in both models using a series of simple NIA solutions and one commercial preparation. The Franz diffusion cell studies were run over 24 h while PAMPA experiments were conducted for 2.5 h. A linear correlation between both models was observed for the cumulative amount of NIA permeated in tested models under finite dose conditions. The corresponding correlation coefficients (r2) were 0.88 for porcine skin and 0.71 for human skin. These results confirm the potential of the PAMPA model as a useful screening tool for topical formulations. Future studies will build on these findings and expand further the range of actives investigated.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Human; Niacinamide; PAMPA; Permeation; Porcine; Skin

Mesh:

Substances:

Year:  2018        PMID: 30529662     DOI: 10.1016/j.ijpharm.2018.11.065

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  8 in total

Review 1.  Human skin models: From healthy to disease-mimetic systems; characteristics and applications.

Authors:  Tânia Moniz; Sofia A Costa Lima; Salette Reis
Journal:  Br J Pharmacol       Date:  2020-08-19       Impact factor: 8.739

2.  An Investigation of the Influence of PEG 400 and PEG-6-Caprylic/Capric Glycerides on Dermal Delivery of Niacinamide.

Authors:  Yanling Zhang; Majella E Lane; David J Moore
Journal:  Polymers (Basel)       Date:  2020-12-04       Impact factor: 4.329

3.  Combined Cutaneous Therapy Using Biocompatible Metal-Organic Frameworks.

Authors:  Seyed Dariush Taherzade; Sara Rojas; Janet Soleimannejad; Patricia Horcajada
Journal:  Nanomaterials (Basel)       Date:  2020-11-25       Impact factor: 5.076

4.  In Vitro-In Vivo Correlation in Dermal Delivery: The Role of Excipients.

Authors:  Avnish Patel; Fotis Iliopoulos; Peter J Caspers; Gerwin J Puppels; Majella E Lane
Journal:  Pharmaceutics       Date:  2021-04-13       Impact factor: 6.321

5.  Dermal Delivery of Niacinamide-In Vivo Studies.

Authors:  Yanling Zhang; Chin-Ping Kung; Fotis Iliopoulos; Bruno C Sil; Jonathan Hadgraft; Majella E Lane
Journal:  Pharmaceutics       Date:  2021-05-14       Impact factor: 6.321

6.  Lanolin-Based Synthetic Membranes for Transdermal Permeation and Penetration Drug Delivery Assays.

Authors:  Cristina Alonso; Ilaria Collini; Meritxell Martí; Clara Barba; Luisa Coderch
Journal:  Membranes (Basel)       Date:  2021-06-15

7.  Topical Delivery of Niacinamide: Influence of Binary and Ternary Solvent Systems.

Authors:  Yanling Zhang; Chin-Ping Kung; Bruno C Sil; Majella E Lane; Jonathan Hadgraft; Michael Heinrich; Balint Sinko
Journal:  Pharmaceutics       Date:  2019-12-10       Impact factor: 6.321

8.  Assessment of Finite and Infinite Dose In Vitro Experiments in Transdermal Drug Delivery.

Authors:  Luisa Coderch; Ilaria Collini; Victor Carrer; Clara Barba; Cristina Alonso
Journal:  Pharmaceutics       Date:  2021-03-10       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.